BCDA Live signals | Maximize Profits with Getagraph.com

SELL 104308 min ago

@ $0.436

Issued: 13 Feb 2024 @ 15:58

Return: -15.52%

Previous signal: Feb 13 - 09:32

Previous signal: Buy

Return: 6.63 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases...

Stats
Today's Volume	68 117.00
Average Volume	356 001
Market Cap	9.89M
EPS	$0 ( 2024-03-27 )
Next earnings date	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.670
ATR14	$0.00400 (1.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-19	Frost Phillip Md Et Al	Sell	129 802	Common Stock
2023-10-18	Blank Andrew Scott	Buy	12 434	Stock Option (right to buy)
2023-10-18	Krasno Richard M	Buy	12 434	Stock Option (right to buy)
2023-10-18	Moyes Jay M	Buy	12 434	Stock Option (right to buy)
2023-10-18	Allen Jim L.	Buy	12 434	Stock Option (right to buy)

INSIDER POWER
68.95
Last 98 transactions
Buy: 2 428 796 \| Sell: 415 660

Volume Correlation

Long: -0.20 (neutral)

Short: -0.13 (neutral)

Signal:(49.919) Neutral

BioCardia Inc Correlation

10 Most Positive Correlations
SVAC	0.897
BNIXU	0.895
ATIF	0.882
SOFI	0.88
NUTX	0.879
MTSL	0.878
CBAT	0.87
DRTT	0.87
BGNE	0.863
ACST	0.86

10 Most Negative Correlations
MTEK	-0.904
SLDP	-0.885
LWAC	-0.884
RBKB	-0.866
NETE	-0.866
MMAC	-0.859
AMRB	-0.85
RMRM	-0.849
SRAC	-0.848
PMD	-0.846

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioCardia Inc Correlation - Currency/Commodity

0.40
( neutral )

0.38
( neutral )

0.00
( neutral )

-0.08
( neutral )

BioCardia Inc Financials

Annual	2023
Revenue:	$477 000
Gross Profit:	$66 000.00 (13.84 %)
EPS:	$-0.550

Q4	2023
Revenue:	$13 000.00
Gross Profit:	$-92 000.00 (-707.69 %)
EPS:	$-0.0875

Q3	2023
Revenue:	$357 000
Gross Profit:	$253 000 (70.87 %)
EPS:	$-0.120

Q2	2023
Revenue:	$43 000.00
Gross Profit:	$-58 000.00 (-134.88 %)
EPS:	$-0.170

Financial Reports:

No articles found.

BioCardia Inc

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.